BioCentury
ARTICLE | Clinical News

Cygnus Therapeutic Systems regulatory update

May 31, 1994 7:00 AM UTC

CYGN (Redwood City, Calif.) said that partner Warner-Lambert resubmitted an NDA for CYGN's seven-day estrogen patch. Prior to accepting NDA, which was filed in January, the FDA requested additional st...